These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 1384826
1. Protease inhibitors in bronchoalveolar lavage fluid from neonates with special reference to secretory leukocyte protease inhibitor. Ohlsson K, Sveger T, Svenningsen N. Acta Paediatr; 1992 Oct; 81(10):757-9. PubMed ID: 1384826 [Abstract] [Full Text] [Related]
4. Secretory leukocyte protease inhibitor and lung inflammation in developing bronchopulmonary dysplasia. Watterberg KL, Carmichael DF, Gerdes JS, Werner S, Backstrom C, Murphy S. J Pediatr; 1994 Aug; 125(2):264-9. PubMed ID: 7913723 [Abstract] [Full Text] [Related]
5. Persistent elastase/proteinase inhibitor imbalance during prolonged ventilation of infants with bronchopulmonary dysplasia: evidence for the role of nosocomial infections. Walti H, Tordet C, Gerbaut L, Saugier P, Moriette G, Relier JP. Pediatr Res; 1989 Oct; 26(4):351-5. PubMed ID: 2797948 [Abstract] [Full Text] [Related]
6. Contribution of additional elastase inhibitors other than alpha 1-protease inhibitor and bronchial antileukoprotease to neutrophil elastase inhibiting capacity of bronchoalveolar lavage. Abboud R, Tsang A, Taller M. Ann N Y Acad Sci; 1991 Oct; 624():315. PubMed ID: 2064232 [No Abstract] [Full Text] [Related]
7. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Ogden BE, Murphy SA, Saunders GC, Pathak D, Johnson JD. Am Rev Respir Dis; 1984 Nov; 130(5):817-21. PubMed ID: 6333839 [Abstract] [Full Text] [Related]
8. Proteinase-antiproteinase balance in tracheal aspirates from neonates. Sluis KB, Darlow BA, Vissers MC, Winterbourn CC. Eur Respir J; 1994 Feb; 7(2):251-9. PubMed ID: 7909297 [Abstract] [Full Text] [Related]
9. Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. Merritt TA, Cochrane CG, Holcomb K, Bohl B, Hallman M, Strayer D, Edwards DK, Gluck L. J Clin Invest; 1983 Aug; 72(2):656-66. PubMed ID: 6603478 [Abstract] [Full Text] [Related]
10. Bronchoalveolar oxyradical inflammatory elements herald bronchopulmonary dysplasia. Contreras M, Hariharan N, Lewandoski JR, Ciesielski W, Koscik R, Zimmerman JJ. Crit Care Med; 1996 Jan; 24(1):29-37. PubMed ID: 8565534 [Abstract] [Full Text] [Related]
11. Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid. Sathe S, Sakata M, Beaton AR, Sack RA. Curr Eye Res; 1998 Apr; 17(4):348-62. PubMed ID: 9561826 [Abstract] [Full Text] [Related]
12. Comparison of concentrations of two proteinase inhibitors, porcine pancreatic elastase inhibitory capacity, and cell profiles in sequential bronchoalveolar lavage samples. Morrison HM, Kramps JA, Dijkman JH, Stockley RA. Thorax; 1986 Jun; 41(6):435-41. PubMed ID: 3491440 [Abstract] [Full Text] [Related]
13. Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome. Sallenave JM, Donnelly SC, Grant IS, Robertson C, Gauldie J, Haslett C. Eur Respir J; 1999 May; 13(5):1029-36. PubMed ID: 10414400 [Abstract] [Full Text] [Related]
14. Effects of dexamethasone and indomethacin on elastase, alpha 1-proteinase inhibitor, and fibronectin in bronchoalveolar lavage fluid from neonates. Gerdes JS, Harris MC, Polin RA. J Pediatr; 1988 Oct; 113(4):727-31. PubMed ID: 2459363 [Abstract] [Full Text] [Related]
15. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Groneck P, Götze-Speer B, Oppermann M, Eiffert H, Speer CP. Pediatrics; 1994 May; 93(5):712-8. PubMed ID: 8165067 [Abstract] [Full Text] [Related]
16. Inhibitors of elastase in airway lavage samples from ventilated preterm human neonates. Griese M, Pudenz P, Gebhard W. Am J Respir Crit Care Med; 1998 Jul; 158(1):256-62. PubMed ID: 9655738 [Abstract] [Full Text] [Related]
17. Studies on the interaction between leukocyte elastase, antileukoproteinase and the plasma proteinase inhibitors alpha 1-proteinase inhibitor and alpha 2-macroglobulin. Fryksmark U, Ohlsson K, Rosengren M, Tegner H. Hoppe Seylers Z Physiol Chem; 1983 Jul; 364(7):793-800. PubMed ID: 6194094 [Abstract] [Full Text] [Related]
18. Alpha 1-proteinase inhibitor and mucus proteinase inhibitor in human lung emphysema. Trefz G, Schliesser J, Heck B, Schulz V, Ebert W. Clin Investig; 1992 Jul; 70(3-4):269-76. PubMed ID: 1521041 [Abstract] [Full Text] [Related]
19. Relationship of proteinases and proteinase inhibitors with microbial presence in chronic lung disease of prematurity. Davies PL, Spiller OB, Beeton ML, Maxwell NC, Remold-O'Donnell E, Kotecha S. Thorax; 2010 Mar; 65(3):246-51. PubMed ID: 20335295 [Abstract] [Full Text] [Related]
20. Low molecular mass bronchial proteinase inhibitor and alpha 1-proteinase inhibitor in sputum and bronchoalveolar lavage. Stockley RA, Morrison HM, Smith S, Tetley T. Hoppe Seylers Z Physiol Chem; 1984 May; 365(5):587-95. PubMed ID: 6332053 [Abstract] [Full Text] [Related] Page: [Next] [New Search]